DBD vs ALRM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 16, 2026
DBD
ALRM
Investment Advisor Scores
ALRM
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DBD | ALRM | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.1655 | 26.2467 | DBD |
| PEG Ratio | 0 | 1.4056 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.0% | 11.0% | ALRM |
| Earnings Growth | 815.4% | -10.3% | DBD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 60.9/100 | 53.7/100 | DBD |
| Profit Margin | 2.8% | 12.4% | ALRM |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | DBD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DBD
NeutralMixed signals - no dominant trend phase, RSI 33
ALRM
MarkupPrice above SMA50, rising 50-day trend (6.9% over 20 days), RSI 65
Fundamentals Snapshot
| Metric | DBD | ALRM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.5 | 18.4 |
| Trailing P/E | 24.9 | 22.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.3% | 0.7% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 2.86 | 2.41 |
| Dividend Yield | — | — |